Search research articles
Contact Us
Filters
Showing results (261-270 of 273) with videos related to
Page
of 28
Sort By:
JAMA Network Open
|
September 17, 2024
Financial Hardship Among Patients With Early-Stage Colorectal Cancer
Gelareh Sadigh, Fenghai Duan, Na An, et al.
The Japanese Journal of Antibiotics
|
September 10, 1999
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]
H Ikemoto, C Ito, T Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2022
Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, et al.
JAMA Oncology
|
September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial
Ghassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
The New England Journal of Medicine
|
June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer
Andrew N J Tutt, Judy E Garber, Bella Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2021
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Michael Gnant, Amylou C Dueck, Sophie Frantal, et al.
The Japanese Journal of Antibiotics
|
September 19, 2001
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)]
K Shimada, K Nakano, I Ohno, et al.
The Japanese Journal of Antibiotics
|
August 3, 2000
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)]
H Ikemoto, M Arakawa, F Gejyo, et al.
Cancer Research Communications
|
July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
JCO Precision Oncology
|
September 3, 2021
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples
Scott A Tomlins, Daniel H Hovelson, Jennifer M Suga, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 273) with videos related to
Sort By:
Page
of 28
JAMA Network Open
|
September 17, 2024
Financial Hardship Among Patients With Early-Stage Colorectal Cancer
Gelareh Sadigh, Fenghai Duan, Na An, et al.
The Japanese Journal of Antibiotics
|
September 10, 1999
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]
H Ikemoto, C Ito, T Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2022
Phase II Study of Copanlisib in Patients With Tumors With <i>PIK3CA</i> Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, et al.
JAMA Oncology
|
September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial
Ghassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
The New England Journal of Medicine
|
June 3, 2021
Adjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer
Andrew N J Tutt, Judy E Garber, Bella Kaufman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 7, 2021
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)
Michael Gnant, Amylou C Dueck, Sophie Frantal, et al.
The Japanese Journal of Antibiotics
|
September 19, 2001
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)]
K Shimada, K Nakano, I Ohno, et al.
The Japanese Journal of Antibiotics
|
August 3, 2000
[Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)]
H Ikemoto, M Arakawa, F Gejyo, et al.
Cancer Research Communications
|
July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.
JCO Precision Oncology
|
September 3, 2021
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples
Scott A Tomlins, Daniel H Hovelson, Jennifer M Suga, et al.
Page
of 28